From 5 November 2026 the Poisons and Therapeutic Goods Act and Regulation will be replaced by the:
This webpage outlines the requirements that will apply from 5 November 2026 onwards.
Cosmetic use substances are Schedule 4 (prescription only) medicines that are used for cosmetic procedures and include:
A medical practitioner or nurse practitioner can only prescribe or give a direction for the administration of a cosmetic substance if the substance:
Before prescribing or giving a written direction for the use of these substances, the prescriber must personally review the patient in person or via video consultation.
A verbal direction is only allowed if the prescriber is physically present at the time of administration.
Written directions are valid for 6 months and must be signed by the medical practitioner or nurse practitioner. The direction must include:
For each cosmetic use substance used for treatment the direction must include the following:
Medical practitioners and nurse practitioners must keep a record of all written or verbal directions.
[back to top]
Cosmetic use substances may only be administered by the following authorised health practitioners:
No other person is permitted to administer cosmetic use substances.
A nurse administering a cosmetic use substance must:
A copy of the administration record must be provided to:
[back to top]
Cosmetic use substances must be stored:
These requirements apply both to clinics generally and to practitioners who obtain substances for administration.
Businesses providing cosmetic procedures must ensure:
Responsible providers (business owners and operators) must keep copies of all:
[back to top]
The Act and Regulation outline penalties for offences associated with unauthorised activities.
Penalties are classified in 5 tiers and differ for individuals and corporations. They range from 20 to 400 penalty units for individuals and 100 to 2000 penalty units for corporations.
Supporting information to help understand the requirements of the legislation are available on the Pharmaceutical Services Medicines, Poisons and Therapeutic Goods legislation webpage. Disclaimer The information on this webpage is provided for general guidance only. While reasonable care has been taken to ensure the accuracy, reliability, and currency of the information, users should refer to the Medicines, Poisons and Therapeutic Goods Act 2022 and the Medicines, Poisons and Therapeutic Goods Regulation 2026 for full and current legal requirements.
The information on this webpage is provided for general guidance only. While reasonable care has been taken to ensure the accuracy, reliability, and currency of the information, users should refer to the Medicines, Poisons and Therapeutic Goods Act 2022 and the Medicines, Poisons and Therapeutic Goods Regulation 2026 for full and current legal requirements.